Last updated: January 10, 2024
Sponsor: Afyonkarahisar Health Sciences University
Overall Status: Completed
Phase
N/A
Condition
Carpal Tunnel Syndrome
Neurologic Disorders
Musculoskeletal Diseases
Treatment
Ultrasound-guided Hydrodissection (HD) with 5 cc 5% Dextrose
Ultrasound-guided Hydrodissection (HD) with 10 cc Normal Saline
Ultrasound-guided Hydrodissection (HD) with 10 cc 5% Dextrose
Clinical Study ID
NCT05222126
CTSHD22
Ages 20-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Presence of symptoms of carpal tunnel syndrome, including nocturnal, postural, ormovement-related paresthesias +/- pain in the median nerve distribution area in thehand for more than 3 months
- Presence of mild to moderate carpal tunnel syndrome proven by electrophysiologicalstudy
- Loss of sensation with numbness in the median nerve-innervated areas of the hand,weakness of the median nerve-innervated thenar muscles
- Positive Phalen test and/or Tinel sign
Exclusion
Exclusion Criteria:
- Patients who can mimic the diagnosis of carpal tunnel syndrome, such as cervicalradiculopathy, polyneuropathy, brachial plexopathy, thoracic outlet syndrome
- Patients who have had an injection into the carpal tunnel in the last 6 months
- Patients with thenar muscle atrophy
- History of Carpal tunnel surgery
- Regular use of systemic nonsteroidal anti-inflammatory drugs and corticosteroids
- Pregnancy
- Rheumatoid arthritis, systemic lupus erythematosus, gout, systemic sclerosis,dermatomyositis, polymyositis
- Presence of malignancy
- Presence of active infection
Study Design
Total Participants: 80
Treatment Group(s): 4
Primary Treatment: Ultrasound-guided Hydrodissection (HD) with 5 cc 5% Dextrose
Phase:
Study Start date:
September 20, 2022
Estimated Completion Date:
January 10, 2024
Study Description
Connect with a study center
Afyonkarahisar Health Sciences University
Afyonkarahi̇sar, 03200
TurkeySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.